Search & Analyze
Popular Searches
Glenmark Pharmaceuticals Ltd.
Healthcare₹2,193.250.61%
24 Jul, 4:01 PM
CMP₹2,193.25
Mkt Cap₹62.24K Cr
P/E45.70
P/B5.92
ROE12.56%
52W High₹2,471.05
52W Low₹1,794.00
Customise metrics bar
Stock DNA
Key Ratios
P/E Ratio
45.70
P/B Ratio
5.92
EV/EBITDA
12.13
Price/Sales
3.72
Dividend Yield (%)
0.11
EPS (TTM ₹)
48.26
Book Value (₹)
372.50
ROE (%)
12.56
ROCE (%)
16.16
ROA (%)
7.42
EBITDA Margin (%)
8.01
Net Profit Margin (%)
3.57
Debt/Equity
0.25
Current Ratio
1.56
Interest Coverage
7.76
Asset Turnover
2.08
Working Capital/Sales
8.82
Core EBITDA Growth (%)
21.12
P&L
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Gross Sales | 109439.29 | 123049.03 | 115832.35 | 118130.97 | 133217.4 |
| Net Sales | 109439.29 | 123049.03 | 115832.35 | 118130.97 | 133217.4 |
| Total Income | 109941.45 | 124715.77 | 118721.36 | 126530.91 | 134354.62 |
| Total Expenditure | 88595.48 | 99846.04 | 99482.3 | 106177.66 | 109703.59 |
| Operating Profit | 21345.97 | 24869.73 | 19239.06 | 20353.25 | 24651.03 |
| Depreciation | 4435.54 | 4867.15 | 5691.74 | 5819.06 | 4860.1 |
| Exceptional Items | 445.45 | -2609.13 | -7658.54 | -9009.55 | -3728.19 |
| Profit Before Tax | 13824.75 | 14412.46 | 2398.42 | 364.95 | 13992.09 |
| Tax | 4123.87 | 4475.97 | 3294.03 | 18673.45 | 3520.67 |
| Profit After Tax (PAT) | 9700.88 | 9936.49 | -895.61 | -18308.5 | 10471.42 |
| EPS (₹) | 34.38 | 33.37 | 10.53 | -53.22 | 37.11 |
| Dividend Payout % | 250 | 250 | 250 | 250 | 250 |
Balance Sheet
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Share Capital | 282.17 | 282.17 | 282.17 | 282.19 | 282.19 |
| Reserves | 70147.78 | 90421.29 | 94280.89 | 78014.77 | 88121.58 |
| Shareholders Funds | 70646.27 | 90866.47 | 94739.23 | 78479.27 | 88494.41 |
| Total Debt | 46874.28 | 36703.49 | 43477.2 | 9905.96 | 21941.95 |
| Total Liabilities | 140689.09 | 153971.65 | 175657.63 | 133089.02 | 149254.45 |
| Total Assets | 140689.09 | 153971.65 | 175657.63 | 133089.02 | 149254.45 |
| Book Value / Share | 249.6011 | 321.4497 | 335.128 | 277.4619 | 313.2775 |
| Assets | 140689.09 | 153971.65 | 175657.63 | 133089.02 | 149254.45 |
Cash Flows
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Operating Activities | 11312.13 | 11086.52 | 6253.92 | -2654.44 | -8275.95 |
| Investing Activities | -6752.36 | -3332.8 | -5284.91 | 45608.93 | 20.94 |
| Financing Activities | -4417.79 | -5204.91 | -774.56 | -39061.27 | 7870.45 |
| Net Cash Flow | 141.98 | 2548.81 | 194.45 | 3893.22 | -384.56 |
GLENMARK
₹2,193.25
+0.61%